Impac, Calypso partner for radiation therapy treatment
Calypso Medical and Impac Medical Systems, an Elekta company, reported that they are collaborating to integrate Impac’s oncology management systems with Calypso’s 4D localization system. The announcement was made at the American Society of Therapeutic Radiology and Oncology meeting in Los Angeles.
The Calypso 4D Localization system monitors patients during treatment without adding ionizing radiation, according to the Seattle-based company. According to Calypso’s president and CEO, Eric Meier, the collaboration with Impac will provide its customers with new approaches to real-time organ motion management from patient setup through treatment.
“We anticipate workflow gains that will further solidify our platform as ideal and unique by providing continuous and real-time target localization solutions,” he said.
With the proposed product integration, customers will be able to more efficiently manage organ motion with the addition of new features such as the capability of remote table repositioning, the firms said. Accurate and precise delivery of radiation treatment will be ensured by correcting for motion detected by the Calypso 4D Localization system prior to and during the actual treatment.
"The real-time motion data generated by the Calypso System introduces new and exciting options which will advance adaptive radiation therapy approaches, as well as provide data management solutions for our mutual customers,” said Jay Hoey, executive vice president product creation at Elekta and CEO of the Sunnyvale, Calif.-based Impac.
The Calypso 4D Localization system monitors patients during treatment without adding ionizing radiation, according to the Seattle-based company. According to Calypso’s president and CEO, Eric Meier, the collaboration with Impac will provide its customers with new approaches to real-time organ motion management from patient setup through treatment.
“We anticipate workflow gains that will further solidify our platform as ideal and unique by providing continuous and real-time target localization solutions,” he said.
With the proposed product integration, customers will be able to more efficiently manage organ motion with the addition of new features such as the capability of remote table repositioning, the firms said. Accurate and precise delivery of radiation treatment will be ensured by correcting for motion detected by the Calypso 4D Localization system prior to and during the actual treatment.
"The real-time motion data generated by the Calypso System introduces new and exciting options which will advance adaptive radiation therapy approaches, as well as provide data management solutions for our mutual customers,” said Jay Hoey, executive vice president product creation at Elekta and CEO of the Sunnyvale, Calif.-based Impac.